Comprehensive Analysis of the Immune and Prognostic Implication of MMP14 in Lung Cancer

Figure 8

Development of a prognostic immune-related risk signature associated with lung cancer patient outcomes. (a) The overall survival of high- and low-risk lung cancer patients was evaluated using Kaplan-Meier curves. (b, c) Risk score distribution, survival status, and gene expression profile of lung cancer patients.

(a)

(b)

(c)